
Hidehito Horinouchi/X
Apr 15, 2025, 13:18
Hidehito Horinouchi: Afatinib in patients with solid tumors with neuregulin1 (NRG1) fusions
Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, posted on X:
“Afatinib in patients with solid tumors with neuregulin 1 fusions: a case series from the TAPUR Study.
Efficacy of afatinib in lung, colorectal, and pancreatic cancers harboring NRG1 fusions – Dr. Jordi Rodon.”
Authors: Jordi Rodon et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 13:00